What Wall Street expects from Kyverna Therapeutics KYTX this quarter KYTX Q4 2025 Kyverna Therapeutics Beats EPS Estimates with Zero Revenue Is BioHarvest BHST stock volatile BioHarvest posts 45 EPS miss no revenue reported Warner Bros Discovery Inc WBD Announces Revised Schedule for First Quarter 2026 Earnings Release and Conference Call FBIOP Fortress reports wider than expected Q4 2025 loss even as shares gain 626 percent today TACHW Titan management outlines key strategic priority of pursuing highgrowth tech acquisition targets this year CREG Smart Powerr shares plunge 3812 after Q3 2023 earnings post a 002 per share loss ALOV Aldabra 4 leadership lays out strategic liquidity allocation priorities in its latest quarterly earnings report EP Empire reports Q3 2025 loss per share of 12 cents stock trades flat on no consensus earnings estimates DXC DXC Tech delivers 15 percent Q1 2026 EPS beat but shares slide 328 percent in todays trading Why Chimera 2029 CIMN is still under the radar Hovering 20260505 Vanguard Energy ETF VDE Positioned for Outperformance Amid Persistent Global Oil Supply Constraints Analog Devices ADI Outpaces Broader Tech Sector A Closer Look at Relative Performance FDP Fresh Del reports huge Q4 2025 EPS beat yet shares dip 105 percent in todays trading Is Curanex CURX a once in a decade opportunity Volatility Increases 20260508